Malaria remains the most important parasitic disease in the world, affecting hundreds of millions of people and killing almost 1 million each year. Anti-malarial drugs remain the mainstay of malaria management, but the emergence and spread of resistance to these drugs is of grave concern. It is apparent that for the foreseeable future we need to feed a robust pipeline with compounds that either overcome drug resistance or target novel physiological processes vital for the parasite. Towards this goal, our laboratory has shown the mitochondrion of malaria parasites to be highly diminished and divergent from its mammalian counterpart, and has validated its physiology as a target for anti-malarial drugs such as atovaquone. We have demonstrated selective inhibition of parasite mitochondrial electron transport chain (mtETC) at the cytochrome bc1 complex by at least 3 additional chemical classes of compounds under development as antimalarials. We showed that a critical function of mtETC in Plasmodium falciparum blood stages was to serve as an electron disposal system for the mitochondrially located dihydroorotate dehydrogenase (DHODH), thereby supporting the essential pyrimidine biosynthesis. Among several implications of this finding, it provided further validation of parasite DHODH as a target for anti-malarial drug development, an effort underway by several groups. Our initial investigations of the ATP synthase complex, ubiquinone-requiring mitochondrial dehydrogenase, and enzymes and architecture of tricarboxylic acid (TCA) metabolism all suggest unusual aspects of mitochondrial functions in malaria parasites. Our results also suggest essential nature of some of these processes with the possibility that they could serve as potential targets for drug development. With greatly improved tools and technology developed over the recent years, we propose to investigate these functions in greater details with the hope that this knowledge could guide search for novel strategies to develop anti-malarial drugs. We will combine the power of genetic manipulation and metabolomic analysis in this investigation to assess contributions made by the two branches of the unusual TCA metabolism of the parasite. We will also examine the role mitochondrial processes during in vivo infection as well as in sexual and mosquito stages of malaria parasites. Finally, we will investigate the unusual ATP synthase as well as mitochondrial respiratory complexes to understand their functional significance and impact on parasite physiology. These studies have the potential to be highly valuable in developing strategies for chemotherapeutic intervention affecting validated targets of malaria parasites.

Public Health Relevance

There is a dire need to develop new anti-malarial drugs that target novel physiological processes of malaria parasites. The unusual mitochondrion of the malaria parasite represents an attractive target that has been validated for anti-malarial drug action. This project aims to derive deeper understanding of additional unusual features of the parasite mitochondrion with a view to eventually guide further strategies for drug development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI028398-23
Application #
8265584
Study Section
Special Emphasis Panel (ZRG1-IDM-S (03))
Program Officer
Rogers, Martin J
Project Start
1989-07-01
Project End
2016-05-31
Budget Start
2012-06-01
Budget End
2013-05-31
Support Year
23
Fiscal Year
2012
Total Cost
$425,186
Indirect Cost
$149,985
Name
Drexel University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
002604817
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Rajgor, D D; Gogtay, N J; Kadam, V S et al. (2014) Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivax. Malar Res Treat 2014:347018
Ke, Hangjun; Sigala, Paul A; Miura, Kazutoyo et al. (2014) The heme biosynthesis pathway is essential for Plasmodium falciparum development in mosquito stage but not in blood stages. J Biol Chem 289:34827-37
Sheiner, Lilach; Vaidya, Akhil B; McFadden, Geoffrey I (2013) The metabolic roles of the endosymbiotic organelles of Toxoplasma and Plasmodium spp. Curr Opin Microbiol 16:452-8
Nilsen, Aaron; LaCrue, Alexis N; White, Karen L et al. (2013) Quinolone-3-diarylethers: a new class of antimalarial drug. Sci Transl Med 5:177ra37
Ehrhardt, Katharina; Davioud-Charvet, Elisabeth; Ke, Hangjun et al. (2013) The antimalarial activities of methylene blue and the 1,4-naphthoquinone 3-[4-(trifluoromethyl)benzyl]-menadione are not due to inhibition of the mitochondrial electron transport chain. Antimicrob Agents Chemother 57:2114-20
Nam, Tae-Gyu; McNamara, Case W; Bopp, Selina et al. (2011) A chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome b inhibitor. ACS Chem Biol 6:1214-22
Painter, Heather J; Morrisey, Joanne M; Vaidya, Akhil B (2010) Mitochondrial electron transport inhibition and viability of intraerythrocytic Plasmodium falciparum. Antimicrob Agents Chemother 54:5281-7
Olszewski, Kellen L; Mather, Michael W; Morrisey, Joanne M et al. (2010) Branched tricarboxylic acid metabolism in Plasmodium falciparum. Nature 466:774-8
Mather, Michael W; Morrisey, Joanne M; Vaidya, Akhil B (2010) Hemozoin-free Plasmodium falciparum mitochondria for physiological and drug susceptibility studies. Mol Biochem Parasitol 174:150-3
Vaidya, Akhil B; Mather, Michael W (2009) Mitochondrial evolution and functions in malaria parasites. Annu Rev Microbiol 63:249-67

Showing the most recent 10 out of 11 publications